Both mix-ups are considered plausible and are discussed by professional societies and reviews, but neither has actually been directly and rigorously measured, so it is more honest to say this is a well-reasoned concern than a proven statistic.
What does exist: reviews describe thyroid symptoms in midlife women as being more subtle and easily attributed to menopause, older patients with an overactive thyroid often present with fewer classic symptoms, and a large share of biochemical thyroid dysfunction in the community goes undetected. In the other direction, a meaningful share of people already on thyroid medication have an out-of-range TSH, and trial evidence shows treating mild thyroid abnormalities usually does not relieve symptoms, both of which suggest that some midlife women may be medicated for a number rather than for a clear symptomatic benefit.
The genuine disagreement here is not between two camps with opposing data, since almost no direct data exists either way; it is between confidently citing a specific misdiagnosis statistic that circulates informally and honestly stating that this remains an unmeasured, though plausible, phenomenon.
What the research shows, and which source each finding rests on
Reviews focused on midlife women state that thyroid disorder diagnosis is challenging in this group because symptoms are more subtle and are commonly attributed to menopause, and a 2024 professional society statement frames the overlap as leading to diagnostic challenges and delayed diagnosis in both conditions.
Older patients with an overactive thyroid often present with a paucity of classic symptoms, which is why reviews explicitly propose a lower testing threshold in older patients.
Among people already taking thyroid medication in one large health-fair study, 40% had an out-of-range TSH, showing both undertreatment and overtreatment are common.
Where the real disagreement is
Each position is shown with its own sources. A position listed here is not necessarily the accepted view.
a specific misdiagnosis statistic is sometimes cited
some public-facing health content
A frequently repeated figure holds that only about one in four women who discussed menopause symptoms with a physician were also tested for thyroid disease; this traces back to a professional-association survey reported as a press release rather than a peer-reviewed study.
the honest position is that this is plausible but unmeasured
a careful reading of the underlying research base
The misdiagnosis phenomenon in both directions is supported by review-level statements, mechanism (subtle symptoms, older patients underpresenting), and indirect population evidence of widespread undetected thyroid dysfunction, but it has never been rigorously measured with a chart audit or diagnostic-delay study, so it should be described as plausible and reasoned, not as a settled statistic.
What would settle it: A dedicated chart-audit or diagnostic-delay study tracking how often thyroid disease is initially attributed to menopause, and vice versa, would settle this. It is named directly as a genuine research gap and has not been done.
What is really going on here
- The often-cited 'only 1 in 4 women were tested for thyroid disease' figure traces to a professional-association press release, not a peer-reviewed study, and should be treated as illustrative rather than as a precise measurement.
- The 'I cured my thyroid condition with hormone therapy' narrative, heard in patient communities, is acknowledged even by sympathetic clinicians in the source material to have no supporting data behind it.
Questions for your doctor
- Before attributing my symptoms to menopause, have we ruled out a thyroid problem with a blood test?
- If I am already on thyroid medication, is my current dose confirmed to be correct with a recent test?
- How would we know if my thyroid medication is genuinely helping versus just correcting a number?
- If I want to explore hormone therapy, should my thyroid status be reassessed at the same time?
Questions with no answer yet
How often is thyroid disease actually mistaken for menopause, and how often is the reverse true, when no chart-audit or diagnostic-delay study has ever directly measured either?
Not directly studied yetNo research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.
What is known: No formal chart-audit or diagnostic-delay study was found quantifying how often thyroid disease in midlife women is initially attributed to menopause, or how often perimenopause is attributed to thyroid disease; both remain named, honest research gaps rather than measured statistics, even though professional societies and reviews describe both as plausible.
What would test it: A dedicated chart-audit or diagnostic-delay study tracking how often thyroid disease is initially attributed to menopause, and vice versa; this is named directly as a genuine research gap and has not been done.
Is the absence of a measured misdiagnosis statistic in either direction because the phenomenon is actually rare, or because no one has funded the kind of large-scale chart-audit study that would be needed to measure it?
Not directly studied yetNo research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.
What is known: The mechanism-level evidence supporting both directions of misdiagnosis is real, including subtle overlapping symptoms, older patients underpresenting classic thyroid symptoms, and widespread undetected thyroid dysfunction in the community, but this remains plausible and reasoned rather than a settled, measured statistic.
What would test it: The same chart-audit or diagnostic-delay study named above; until it exists, the true frequency of either misdiagnosis direction remains unknown rather than established as common or rare.
Sources
- 1.Thyroid disease in the perimenopause and postmenopause period.Uygur MM, Yoldemir T, Yavuz DG. Thyroid disease in the perimenopause and postmenopause period. Climacteric 2018;21(6):542-548. · Systematic review or guideline
- 2.EMAS position statement: Thyroid disease and menopause.Mintziori G, Anagnostis P, Armeni E, et al. EMAS position statement: Thyroid disease and menopause. Maturitas 2024;185:107991. · Systematic review or guideline
- 3.Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study.Boelaert K, Torlinska B, Holder RL, Franklyn JA. Older subjects with hyperthyroidism present with a paucity of symptoms and signs. J Clin Endocrinol Metab 2010;95(6):2715-2726. · Comparative or small study
- 4.The Colorado thyroid disease prevalence study.Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160(4):526-534. · Comparative or small study
- 5.Thyroid disease in the perimenopause and postmenopause period.Uygur MM, Yoldemir T, Yavuz DG. Thyroid disease in the perimenopause and postmenopause period. Climacteric 2018;21(6):542-548. · Systematic review or guideline
- 6.American Association of Clinical Endocrinologists survey, as reported in secondary health-information coverage (provenance is a press release, not a peer-reviewed study).Review, opinion or mechanism
The letter grades the type of study behind a claim, not the answer itself.
This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.
You are not imagining it
In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.
Start Free MappingRelated questions
- How do I know if my symptoms are from my thyroid or from perimenopause?
- Could what I am feeling actually be a thyroid problem rather than perimenopause?
- Which thyroid tests should I actually ask for?
- Is a 'normal' TSH result actually good enough, or should it be lower to be truly optimal?
- Will starting hormone therapy change how much thyroid medication I need?
- What is Hashimoto's disease, and how does it relate to perimenopause?
- Back to topic: Thyroid and perimenopause